Related Experiment Video
Updated: Jan 25, 2026

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples
Published on: March 14, 2014
The American Cancer Society 2035 challenge goal on cancer mortality reduction
Jiemin Ma1, Ahmedin Jemal2, Stacey A Fedewa1
1Senior Principal Scientist, Surveillance and Health Services Research Program, American Cancer Society, Atlanta, GA.
Abstract:
A summary evaluation of the 2015 American Cancer Society (ACS) challenge goal showed that overall US mortality from all cancers combined declined 26% over the period from 1990 to 2015. Recent research suggests that US cancer mortality can still be lowered considerably by applying known interventions broadly and equitably. The ACS Board of Directors, therefore, commissioned ACS researchers to determine challenge goals for reductions in cancer mortality by 2035. A statistical model was used to estimate the average annual percent decline in overall cancer death rates among the US general population and among college-educated Americans during the most recent period. Then, the average annual percent decline in the overall cancer death rates of college graduates was applied to the death rates in the general population to project future rates in the United States beginning in 2020. If overall cancer death rates from 2020 through 2035 nationally decline at the pace of those of college graduates, then death rates in 2035 in the United States will drop by 38.3% from the 2015 level and by 54.4% from the 1990 level. On the basis of these results, the ACS 2035 challenge goal was set as a 40% reduction from the 2015 level. Achieving this goal could lead to approximately 1.3 million fewer cancer deaths than would have occurred from 2020 through 2035 and 122,500 fewer cancer deaths in 2035 alone. The results also show that reducing the prevalence of risk factors and achieving optimal adherence to evidence-based screening guidelines by 2025 could lead to a 33.5% reduction in the overall cancer death rate by 2035, attaining 85% of the challenge goal.
Insights
The American Cancer Society (ACS) set a 2035 goal to reduce cancer mortality by 40% by applying known interventions broadly and equitably. Achieving this goal could prevent over 1.3 million cancer deaths.
Area of Science:
- Oncology
- Public Health
- Biostatistics
Background:
- US cancer mortality declined 26% from 1990 to 2015.
- Known interventions can significantly lower cancer deaths if applied equitably.
- The American Cancer Society (ACS) aimed to establish new cancer mortality reduction goals.
Purpose of the Study:
- To determine challenge goals for cancer mortality reductions by 2035.
- To project future US cancer death rates based on recent trends.
- To estimate the potential impact of achieving these goals on cancer deaths.
Main Methods:
- A statistical model was used to estimate annual percent declines in cancer death rates.
- The decline rate observed in college-educated Americans was applied to the general population projections.
- Calculations projected cancer death rates from 2020 through 2035.
Main Results:
- A 40% reduction in cancer death rates from 2015 levels by 2035 is achievable.
- This goal could result in approximately 1.3 million fewer cancer deaths between 2020-2035.
- Reducing risk factors and improving screening adherence could achieve 85% of the goal by 2035.
Conclusions:
- The ACS 2035 challenge goal is set at a 40% reduction in cancer mortality.
- Achieving this goal has the potential to save over 1.3 million lives.
- Public health strategies focusing on risk factors and screening are crucial for reaching the goal.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Psychosis: Goals of Pharmacotherapy
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

